(Q38003050)

26 August 2017

title

Management of polyomavirus-associated nephropathy in renal transplant recipients (English)

1 reference

polyomavirus-associated nephropathy

26 August 2017

main subject

1 reference

Dirk R J Kuypers

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

17 April 2012

1 reference

Nature Reviews Nephrology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

390-402

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2012.64

26 August 2017

exact match

0 references

cites work

An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Risk factors for polyoma virus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Treatment for BK virus: incidence, risk factors and outcomes for kidney transplant recipients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Genomic mutations of viral protein 1 and BK virus nephropathy in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Mutations in the external loops of BK virus VP1 and urine viral load in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Early events during BK virus entry and disassembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Transforming growth factor-beta-mediated regulation of BK virus gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Urinary proinflammatory cytokine response in renal transplant recipients with polyomavirus BK viruria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK virus antibody titers and intensity of infections after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of bk virus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK-VP3 as a new target of cellular immunity in BK virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK virus-specific immunity kinetics: a predictor of recovery from polyomavirus BK-associated nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK polyomavirus infection and nephropathy: the virus-immune system interplay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Evaluation of a preemptive strategy for BK polyomavirus-associated nephropathy based on prospective monitoring of BK viremia: a kidney transplantation center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Monitoring of BK viral load in renal allograft recipients by real-time PCR assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Monitoring of BK virus replication in the first year following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Quantitation of BK virus DNA for diagnosis of BK virus-associated nephropathy in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Cost-efficient screening for BK virus in pediatric kidney transplantation: a single-center experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Prospective study of urine cytology screening for BK polyoma virus replication in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Prospective monitoring of BK virus replication in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Screening to prevent polyoma virus nephropathy in kidney transplantation: a cost analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Presence of urinary Haufen accurately predicts polyomavirus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Surveillance and modification of immunosuppression minimizes BK virus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Clinical course of polyoma virus nephropathy in 67 renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Human polyoma virus-associated interstitial nephritis in the allograft kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus Allograft Nephropathy: Sequential Assessment of Histologic Viral Load, Tubulitis, and Graft Function Following Changes in Immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: the need for true drug exposure measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Preemptive Retransplant for BK Virus Nephropathy Without Concurrent Transplant Nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Activities of different classes of acyclic nucleoside phosphonates against BK virus in primary human renal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Leflunomide inhibition of BK virus replication in renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Conformational rearrangements of SV40 large T antigen during early replication events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Therapeutic implications of renal anionic drug transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Anti-BK virus activity of ciprofloxacin and related antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus BK neutralizing activity in human immunoglobulin preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Viral drug sensitivity testing using quantitative PCR: effect of tyrosine kinase inhibitors on polyomavirus BK replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Suppression of early and chronic BK polyoma virus replication by mycophenolic acid in Vero cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

In vitro effect of cyclosporin A on primary and chronic BK polyoma virus infection in Vero E6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

A suppressive effect of cyclosporine A on replication and noncoding control region activation of polyomavirus BK virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Inhibition of human BK polyomavirus replication by small noncoding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Antiviral therapy for polyomavirus-associated nephropathy after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Monitoring the progress of BK virus associated nephropathy in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus BK nephropathy: the effect of an early diagnosis on renal function or graft loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Treatment of renal allograft polyoma BK virus infection with leflunomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

KDIGO clinical practice guideline for the care of kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK virus in solid organ transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Real-Time RT-PCR Assay for the Quantitation of Polyomavirus BK VP1 mRNA Levels in Urine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Polyomavirus-infected decoy cells in cytocentrifuged urine cytology specimens from renal transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Association of immune cell function assay with protocol biopsy findings and viral infections in well matched kidney transplant recipients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Retransplantation after polyomavirus-associated nephropathy: just do it?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2012.64

Assessment of Efficacy and Safety of FK778 in Comparison With Standard Care in Renal Transplant Recipients With Untreated BK Nephropathy

31 March 2020

1 reference

12 December 2020

Aggressive post-transplant monitoring of more importance to successful outcome following re-transplantation for BK virus nephropathy than absence of pretransplant viremia

1 reference

12 December 2020

Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN.

1 reference

12 December 2020

Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones.

1 reference

12 December 2020

Detection of polyomavirus BK reactivation after renal transplantation using an intensive decoy cell surveillance program is cost-effective.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2012.64

1 reference

Dimensions Publication ID

26 August 2017

1002594882

0 references

1 reference